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Background: The Regensburg Insomnia Scale (RIS) is a new self-rating scale to assess cognitive, emotional and
behavioural aspects of psychophysiological insomnia (PI) with only ten items. A specific purpose of the new scale is
the evaluation of the outcome of insomnia- specific cognitive behaviour therapy (CBT-I).
Methods: Internal consistency of the RIS has been validated in 218 patients with PI. For determining sensitivity and
specificity, this sample has been compared to 94 healthy controls. Sensitivity to change and pre-post cross-validation
with the Pittsburgh Sleep Quality Index (PSQI) has been tested in a separate sample of 38 patients with PI
undergoing CBT-I.
Results: RIS distinguishes well between controls and patients with PI. Internal consistency was within a good
range (Cronbach alpha = .890). RIS was sensitive for detecting improvements after CBT-I in sleep parameters and
target symptoms such as sleep-related thinking.
Conclusion: The RIS is a valid and feasible instrument for assessing psychological PI-symptoms and sleep
parameters.
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Insomnia is a frequent disorder with prevalences varying
between 2% [1] and 48% [2] depending on the diagnostic
criteria used. It is often associated with psychiatric and
organic diseases and produces costs due to accidents
and absentieesm [3-5]. Several tools for measuring in-
somnia have been developed [6-9] reflecting the growing
interest and need for assessment instruments in insom-
nia research. However, there still is a need for a short* Correspondence: tatjana.croenlein@medbo.de
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reproduction in any medium, provided the orscale measuring the psychological aspects of insomnia
together with quantitative aspects of sleep.
Why measure the psychological aspects of insomnia?
The reason is that there is growing evidence that
psychological symptoms are prominent, perpetuating
factors for disturbed sleep [10,11], which can be best
seen in psychophysiological insomnia [12] (PI). Psycho-
logical aspects such as sleep related worries and rumin-
ation, dysfunctional attitudes toward sleep [13], distorted
sleep perception [14] and hyperarousal [15] have been
found and investigated thoroughly. It is assumed that
insomnia-specific hyperarousal [16] is fuelled by dys-
functional beliefs (such as “I have to sleep at least 8 hoursl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Crönlein et al. Health and Quality of Life Outcomes 2013, 11:65 Page 2 of 8
http://www.hqlo.com/content/11/1/65per night”) and by the anticipating the negative conse-
quences of sleep loss. Thus, while trying to fall asleep,
enhanced self observation occurs, which in return has
an impairing effect on sleep onset [17]. The relevance of
psychological aspects in the continuance of chronic
insomnia is increasingly being recognized and specific
psychotherapeutic treatments such as Cognitive Behav-
iour Therapy for Insomnia (CBT-I) have been developed
and tested [18-20]. The psychological impact makes it
plausible, that PI is comorbid in other sleep disorders
such as sleep apnea [21] or Periodic Leg Movement in
sleep [22] and the co-existence explains why sleep will
not improve by treating the organic disorder [21] alone.
In order to assess the psychophysiological components
in sleep disorders, a short scale would be useful in clin-
ical routine.
Indeed, there are already a variety of scales assessing
psychological aspects of insomnia. For measuring the
state of cognitive and somatic arousal there is the Pre-
Sleep Arousal Scale [23], the Presleep Cognitive Activity
Questionnaire [24] and the Arousal Level as Present
State [25]. The Metacognitions Questionnaire-Insomnia
(MSQ-I) [26] and the Dysfunctional and Attitudes about
Sleep scale [27] have been developed to measure
insomnia-specific worrisome thoughts and beliefs. The
Thought Control Questionnaire-Insomnia revised scale
[28] measures the attempts to control unwanted
thoughts in insomnia. The Utility of Presleep Worry
Questionnaire (UPWQ) was developed to investigate the
utility of presleep worry in insomnia [29] as well as the
Sleep Disturbance Questionnaire [30]. The Monitoring
for Sleep-Related Threat [31] measures the stimuli that
might hinder falling asleep. The Glasgow Sleep Effort
Scale was designed to measure the attempt to control
the process of falling asleep [32]. All these scales cover
psychological aspects of insomnia, however they are too
specific for clinical routine, since they each just measure
certain symptoms, such as arousal state or presleep
worrying.
The Insomnia Severity Index (ISI) [6] is the most
established instrument for measuring insomnia symp-
toms, however there is only one out of 7 items that tar-
gets the psychological symptoms, namely being worried
about the current sleep pattern. Violani’s Insomnia Scale
[9] covers different items such as medication intake,
snoring, consulting a doctor, in addition to sleep related
items, however this scale does not address clinical
psychophysiological symptoms of insomnia and was
rather designed for the pre-screening of subjects with
insomnia complaints.
A short scale covering quantitative aspects of sleep as
well as insomnia specific symptoms is still lacking. Thus
we aimed at developing a short new instrument for the
assessment of the typical psychological aspects of PI thatcan be especially used for the evaluation of therapeutic
interventions. This scale was validated using a large sam-
ple of insomnia patients and healthy controls. Moreover
we evaluated the scale’s sensitivity to therapeutic
changes in patients with PI who were treated with CBT-
I in our hospital. The Regensburg Insomnia Scale (RIS)
was administered before and 6 months after completion
of therapy. The study was approved by the Ethics Com-
mittee of the University of Regensburg.
Methods
Construction of the scale
The RIS was designed in German. In a pre-study, three
sleep experts who routinely work with insomnia patients
compiled typical complaints of PI patients. Emphasis
was placed on the exact wording, such as “I wake up
from the slightest sound”. To identify insomnia specific
items, this list was given to patients with sleep-apnea
(N = 33), insomnia (N = 36) and to healthy controls
(N = 29). Items that did not discriminate between insom-
nia patients and controls or between insomnia and sleep
apnea patients (Mann-Whitney-Test) were eliminated.
The remaining list was further shortened to the de-
mands of a short and practicable scale measuring sleep
and cognitive, emotional and behavioural symptoms of
PI. Five items were selected to cover quantitative and
qualitative sleep parameters: Sleep latency (1), sleep dur-
ation (2), sleep continuity (3), early awakening (4) and
sleep depth (5). Four items ask about the psychological
aspects of PI, such as the experience of sleepless nights
(6), focussing on sleep (7), fear of insomnia (8), and
daytime fitness (9), one item is about sleep medication
(10). A 5-step Likert scale was provided for response.
This type of scale was also used for quantitative sleep
parameters (sleep duration and sleep latency), because,
according to our clinical experience, insomnia patients
have difficulties giving exact answers when asked about
quantitative data.
The total score ranges from 0 to 40 points. The intro-
ductory question regarding bedtime hours is not in-
cluded in the score. It serves as a plausibility check (for
example to check whether time in bed matches duration
of sleep and sleep latency). After validation of the German
version, the English version of the RIS was created by sleep
experts fluent in both languages using back-and-forth
translation (Table 1).
Sample
After construction of the scale test properties have been
investigated in two separate samples of patients with PI:
one sample in which normative data (NORM) were
gathered and one additional sample of patients who
were tested before and after CBT-I (THERAPY). Patients
were recruited from inpatients and outpatients of the
Table 1 Regensburg insomnia scale
PLEASE RATE THE FOLLOWING QUESTIONS FOR THE LAST FOUR WEEKS
DIE FRAGEN BEZIEHEN SICH AUF DIE LETZTEN VIER WOCHEN
0 AT WHAT TIME DO YOU USUALLY GO TO BED? WHEN DO YOU USUALLY GET UP?
0. MEINE ÜBLICHEN BETTZEITEN SIND VON UHR BIS UHR
1. How many minutes do you need to fall asleep? 1–20 min. 21–40
min.
41–60 min. 61–90
min.
91 min. and
more
1. Wie viele Minuten brauchen Sie zum Einschlafen? 0 1 2 3 4
2. How many hours do you sleep during the night? 7 h and
more
5–6 h 4 h 2–3 h 0–1 h
2. Wie viele Stunden schlafen Sie in der Nacht? 0 1 2 3 4
How often do the following occurrences happen? Always Mostly Sometimes Seldom Never
Wie oft treffen folgende Ereignisse zu? Immer Meistens Manchmal Selten Nie
3. My sleep is disturbed 4 3 2 1 0
3. Ich kann nicht durchschlafen
4. I wake up too early 4 3 2 1 0
4. Ich wache zu früh auf
5. I wake up from the slightest sound 4 3 2 1 0
5. Ich wache schon bei leichten Geräuschen auf
6. I feel that I have not slept all night 4 3 2 1 0
6. Ich habe das Gefühl, die ganze Nacht kein Auge zugetan zu haben
7. I think a lot about my sleep 4 3 2 1 0
7. Ich denke viel über meinen Schlaf nach
8. I am afraid to go to bed because of my disturbed sleep 4 3 2 1 0
8. Ich habe Angst ins Bett zu gehen, da ich befürchte nicht schlafen zu
können.
9. I feel fit during the day 0 1 2 3 4
9. Ich fühle mich voll leistungsfähig
10. I take sleeping pills in order to get to sleep 4 3 2 1 0
10. Ich nehme Schlafmittel, um einschlafen zu können
English and German version.
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and Psychotherapy, University Regensburg (Germany). All
patients have been seen by a psychiatrist and a psychother-
apist. The inclusion criterion for the insomnia patient
sample was a diagnosis of PI according to International
Classification of Sleep Disorders-2 (ICSD-2) [12], irrespect-
ive of the intake of hypnotics. In case a sleep apnea or
Periodic Limb Movements in Sleep was suspected a moni-
toring with an apnea screening instrument or a high reso-
lution actigraphy respectively would be done. Inpatients
had a routine polysomnography. Current or past continu-
ous shift work or night work and current severe physical or
mental disorders with a major influence on sleep were
exclusion criteria. All participants signed informed consent
forms.
NORM was a sample of 218 PI patients with a mean age
of 48.9 ± 13.8 yrs (88 males, mean age 50.0 ± 13.4 yrs; 130
females, mean age: 48.0 ± 14.0 yrs) and a prior mean dur-
ation of insomnia of 9.5 ± 9.5 yrs. 33 patients wereinpatients admitted for treatment of severe chronic insom-
nia, 47 inpatients were admitted for diagnostic purposes
and 138 patients were recruited from the outpatient clinic.
All patients were seeking help in specialized center for
sleep.
THERAPY consisted of 30 women (mean age: 57.7 ±
11.3 yrs) and 8 men (mean age 51.1 ± 11.2 yrs) who
participated in a standardized CBT-I program in our
sleep center [33,34] as inpatients. 21 patients were
taking hypnotics prior to admission. Patients agreed to
discontinue all sleep medication during the program.
The CBT-I program is a standardized two-week pro-
gram based on current psychotherapy standards for
insomnia and includes polysomnography, bedtime re-
striction, relaxation therapy, stimulus control therapy
and a psychoeducational component aimed at correcting
dysfunctional beliefs [10,13]. All patients completed a RIS
and a Pittsburgh Sleep Quality Index (PSQI) [35] at base-
line and 6 months later.
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healthy controls were investigated (mean age: 46.8 ±
12.9 yrs; 42 men; mean age: 50.0 yrs ± 13.0; 52 women;
mean age 44.2 ± 12.3 yrs). The control sample was
recruited from relatives of patients, the hospital staff
and their relatives in different cities of Germany.
Persons in all test samples were different from those
patients and controls that were tested in the construc-
tion period. Controls also filled out a PSQI. Exclusion
criteria were: 1. current or past complaint of disturbed
sleep or excessive daytime sleepiness 2. current or past
continuous shift work or night work; 3. intake of hyp-
notics, 4. current severe physical or mental disorder
with a major influence on sleep. No differences in age
and sex distribution were found between PI patients
(NORM) and controls (students’ t-test, n.s.).Test properties
Normative data (mean scores and mean item scores)
were gathered from the NORM group and controls.
Cronbachs alpha as well as a corrected item-total correl-
ation were calculated. Specificity and sensitivity was
tested in the samples of PI and controls for RIS and for
PSQI separately. A component analysis was done with
Varimax rotation in the insomnia sample. The loading
cut-off chosen to determine which items loaded on a
factor was 0.6.
In order to measure sensitivity of the RIS for therapy-
related changes, the RIS total scores, single items and
PSQI scores (total and subscales) before and after ther-
apy were compared with participants’ t-test. The effect
sizes were calculated with Cohen’s d.Table 2 Means and standard deviations and percentages in R
RIS Items Mean (SD) An
1–20 min. 21–40
1. Sleep latency 1.82 (1.37) 21.1 24
7 h and more 5–
2. Sleep duration 1.65 (0.86) 7.3 37
Never Seld
3. My sleep is disturbed 3.11 (0.97) 0.5 7
4. I wake up too early 2.86 (1.03) 2.8 7
5. I wake up from the slightest sound 2.77 (1.08) 3.2 10
6. I feel that I have not slept all night 2.07 (0.97) 6.9 17
7. I think a lot about my sleep 2.41 (0.92) 2.8 11
8. I am afraid to go to bed because of
my disturbed sleep
1.89 (1.24) 17.0 21
9. I feel fit during the day 2.31 (1.03) 2.3 23
10. I take sleeping pills in order to get
to sleep
1.7 (1.56) 35.8 12
* Item-total correlations relate to the full scale and not the four subscales.Results
Discriminative power
The mean RIS score for the sample was 22.6 points with
a standard deviation of 5.19. The mean score for single
items ranged from 1.65 (item 2 “short sleep duration”)
to 3.11 (item 3 “disturbed sleep continuity”). The major-
ity of responses for all items were in the range from 2 to
4 points, which points to relevant pathology. The full
range of possible responses was used for all items
(Table 2). The RIS score distribution showed a clear bi-
modal distribution with a relatively small overlap between
10 and 14 points (Figure 1). The median score of 22 in PI
patients is significantly higher than the score of the control
group (5 points, Mann-Whitney U = 36; p < .0005). With a
cut-off score of 12 points, sensitivity was 97.7% for insom-
nia patients and specificity was 97.9% for the normal con-
trol sample. Sensitivity of PSQI (cut-off score = 6 points)
was 98% and specificity was 98%.
Reliability
Cronbach’s alpha was calculated for the whole sample.
With an alpha of .890 internal consistency was good.
Corrected item-total correlation with the full scale showed
high correlation coefficients for all items (see Table 2).
Dimensions of the scale
Component analysis with Varimax rotation was performed
in the NORM sample. Statistical analyses were performed
with SPSS 15 (SPSS Inc.). Rotated component analysis re-
vealed four components (Table 3). The first component
comprises the items 3–5 (“disturbed sleep continuity”, “easy
awakening” and “early awakening”) and is labelled “sleep
depth”. It explains 20.56% of the variance (Eigenvalue:IS in 218 patients with psychophysiological insomnia
swer distribution (percentage) Corrected item-total
correlation
min. 41–60 min. 61–90 min. 91 min. and more
.8 21.6 16.1 16.5 .549
6 h 4 h 2–3 h 0–2 h
.2 40.8 12.8 1.8 .694
om Sometimes Mostly Always
.3 17.4 30.7 44.0 .732
.3 22.9 35.3 31.7 .650
.1 23.4 33.5 29.8 .619
.0 44.0 26.1 6.0 .748
.5 37.6 38.1 10.1 .673
.1 29.8 20.6 11.5 .676
.9 26.6 35.3 11.9 .508
.4 18.8 12.4 20.6 .519
Figure 1 Distribution of RIS scores of 218 patients with psychophysiological insomnia and 94 controls.
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ance (Eigenvalue: 1.78); it includes items 1, 2 and 6, which
are related to sleep quantity (“prolonged sleep latency”,
“short sleep duration” and “sleepless nights”) and is called
“sleep quantity”. The third component includes items 7 and
8 (“thinking about sleep” and “fear of insomnia”) and
explains 14.95% of the variance (Eigenvalue: 1.31), it is
labelled “fearfully focussing on insomnia”. The last factor
includes the items 9 and 10 (“impaired daytime fitness” and
“hypnotics intake”) and explains 12.0% of the variance
(Eigenvalue: 1.07). It is called “hypnotics and daytime
functioning”.Table 3 Component analysis with Varimax rotation of the RIS
RIS Items I II
1. Sleep latency −.29 .70
2. Sleep duration .44 .69
3. Sleep continuity .81 .08
4. Early awakening .79 −.04
5. Easy awakening .65 .10
6. Sleepless nights .19 .71
7. Thinking about sleep .15 −.14
8. Fear of insomnia −.07 .42
9. Impaired daytime .03 .25
10. Hypnotic intake .05 .29
Variance 20.56% 18.52%
Component I: Sleep depth, Component II: Sleep quantity, Component III: Fearfully fo
medication/daytime functioning.Treatment effects
Both RIS and PSQI were sensitive for the effects of CBT-I
in the THERAPY sample (see Table 4). All items of RIS ex-
cept “sleep duration” (item 2) were significantly improved.
In the PSQI there was a significant reduction in all subscale
scores except for duration of sleep, sleep disorders and
daytime fitness. Cohen’s d revealed strong effects for RIS
item 10”hypnotics intake” (d = 0.95) after six months,
this effect is also seen in the PSQI (Cohen’s
d = 0.97). Effects on sleep latency are comparable in RIS
and PSQI with Cohen’s d = 0.44 and 0.45 respectively. Both
scales are also comparable regarding effects on sleepin 218 insomnia patients
III IV Communalities
.01 .33 0.68
−.10 −.08 0.69
−.01 .04 0.66
.00 .02 0.63
−.14 −.08 0.47
.26 −.27 0.68
.90 .02 0.85
.74 .13 0.75
.04 −.73 0.61
.19 .67 0.58
14.95% 12.01%
cussing on insomnia and component IV: Sleep
Table 4 Pre post data of 38 patients with PI who had been treated with CBT-I
Item Baseline Post (6 months) Participants’ t-test Effect size d
Mean (SD) Mean (SD)
RIS score 23.45 (4.8) 16.05 (5.36) 9.52 (p < .0005) 0.37
1. Sleep latency 1.87 (1.39) 1.13 (0.87) 3.37 (p = .002) 0.44
2. Sleep duration 1.87 (1.12) 1.68 (1.22) n.s.
3. Sleep continuity 3.37 (1.12) 2.97 (1.22) 2.57 (p = .014) 0.29
4. Early awakening 3.16 (1.03) 2.79 (1.02) 2.67 (p = .011) 0.36
5. Easy awakening 2.55 (1.15) 2.11 (1.20) 2.67 (p = .011) 0.37
6. Sleepless nights 1.82 (1.04) 1.39 (0.95) 2.20 (p = .034) 0.43
7. Thinking about sleep 2.24 (0.92) 1.68 (0.93) 3.70 (p = .001) 0.78
8. Fear of insomnia 1.61 (1.17) 1.18 (1.11) 2.46 (p = .019) 0.32
9. Impaired daytime 2.37 (1.02) 2.00 (1.15) 2.06 (p = .046) 0.32
10. Hypnotic intake 2.61 (2.60) 0.79 (0.79) 6.12 (p < .0005) 0.95
PSQI score 14.37 (2.52) 11.29 (3.52) 5.56 (p < .0005) 0.34
1. Sleep quality 2.05 (0.65) 1.66 (0.81) 3.58 (p = .001) 0.60
2. Sleep latency 2.16 (1.05) 1.66 (1.05) 3.24 (p = .003) 0.45
3. Sleep duration 2.68 (0.57) 2.47 (0.73) n.s.
4. Sleep efficiency 2.63 (0.63) 2.18 (0.98) 2.82 (p = .008) 0.61
5. Sleep disorders 1.21 (0.53) 1.34 (0.53) n.s.
6. Hypnotics intake 2.08 (1.30) 0.66 (1.10) 6.50 (p < .0005) 0.97
7. Daytime sleepiness 1.55 (0.92) 1.31 (0.84) n.s. n.s.
Means and standard deviation of scores and items of RIS and subscales of PSQI. Cohen’s d values for effect sizes of CBT-I.
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rameters in subscales sleep quality and sleep efficiency. The
effects on sleep parameters in RIS are negligible. The RIS
reveals a major effect in item 7 “thinking about sleep” and
minor effects in “fear of insomnia” (item 8) and “sleepless
nights” (item 6).Feasibility
No participant reported problems in understanding or
completing the scale. Completion of the scale took the pa-
tients an average of approximately two minutes. The score
can be calculated within less than a minute. Thus both
completion and evaluation of the scale is much less time
consuming as compared to other scales, e.g. the Pittsburgh
Sleep Quality Index (PSQI).Discussion
The RIS is a new self-rating scale with ten items, devel-
oped to measure symptoms of PI with special emphasis
on psychological symptoms.
The scale covers the characteristic cognitive, emo-
tional and behavioural aspects of PI. These items are
essential target symptoms in CBT-I [36,37]. With an
average time for completion and evaluation of less than
three minutes, it is a highly efficient tool both for re-
search and clinical practice. The RIS discriminates well
between PI and healthy controls. We propose toconsider a score from 0–12 points as normal and a
higher score as indicative of PI symptoms.
The relatively high sensitivity and specificity values of
our scale may be explained by the fact that patients were
recruited from a tertiary referral center with many
insomnia patients showing high symptom load and a se-
vere degree of insomnia. This is illustrated by the finding
that the sensitivity and specificity of the PSQI in our
samples were similarly high and even higher than in the
original study [35]. Final conclusions about the sensitiv-
ity and specificity of the RIS would therefore require
additional studies in independent samples. However, it
should be noted that the RIS has neither been designed
nor validated as a tool for the diagnosis of PI or for dif-
ferentiating between subtypes of insomnia.
Component analysis revealed that the RIS differentially
assesses four factors. Besides “sleep depth” and quantita-
tive aspects of sleep, the factor “fearfully focussing on in-
somnia” is especially interesting for an insomnia scale.
We consider that the combination of psychological as-
pects that characterize psychophysiological insomnia as
well as qualitative and quantitative aspects of sleep all
represented in one short scale is the innovative aspect of
this scale when compared to existing insomnia scales.
Although this multifaceted structure of the RIS indicates
its potential for differential assessment of different dimen-
sions of insomnia (sleep quality, sleep quantity, focus on in-
somnia and medication intake) it should be noted that the
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should also be primarily used so.
The RIS was sensitive for detecting improvements
after CBT-I in sleep parameters and target symptoms.
Both the PSQI and RIS were comparable in measuring
effects of CBT-I on sleep latency, sleep duration and
hypnotic intake. In addition, the RIS detected effects in
target symptoms of CBT-I, especially in thinking about
sleep. This is an important result, since modification of
dysfunctional beliefs is one of the central aspects of
CBT-I [37]. Effects were also seen in sleep-related fear,
indicating the sensitivity of the RIS to the emotional as-
pects of PI. The changes observed in the perception of
sleeplessness suggest that the RIS also covers sleep mis-
perception, which is regarded as one of the central as-
pects of PI [14,38] . Thus similar to the ISI [6] and the
Dysfunctional Beliefs and Attitudes about Sleep Scale
[27], the RIS is sensitive to psychotherapy-specific target
symptoms and is therefore proposed as a complemen-
tary scale with a special focus on psychological symp-
toms of PI.
Beyond measuring severity of PI, RIS (and especially
its different dimensions) may be a useful instrument in
disentangling the psychological symptoms from the
symptoms of the organic sleep disorders. In a recently
published study, we showed that psychophysiological
insomnia-specific symptoms contribute to a less compli-
ant attitude towards a treatment of sleep apnea with
continuous positive airway pressure [39]. This study was
done with the RIS and showed new aspects in compari-
son to another study that was performed with the ISI
earlier [40]. While Nuygen et al., could not see any
impact of insomnia symptoms on CPAP compliance
with the ISI, two items in the RIS (“I feel that I have
not slept all night” and “I am afraid to got to bed be-
cause of my disturbed sleep”) specifically correlated
with compliance [39].
There are limiting factors in this study design. In this
study the RIS has been validated using a sample of in-
somnia patients with a broad spectrum of severity, ran-
ging from outpatients to patients who received inpatient
CBT-I. This is reflected by the broad distribution of the
scores (Figure 1). Nevertheless, a potential selection bias
cannot be excluded since the sample stems from a spe-
cialized tertiary referral centre. Therefore evaluation of
the RIS in other samples is strongly encouraged. For the
English version normative studies are necessary. Further
studies should also investigate the relation to objective
sleep data and the comparability to other short insomnia
scales recently published. Also the sensitivity of the RIS
for other therapeutic interventions such as pharmaco-
therapy should be addressed. In addition it was not vali-
dated against objective measures such as actigrapy or
polysomnography. However, since this scale focuses onpsychological symptoms and since a wide range in ob-
jective sleep parameters in insomnia patients are known
[41], we consider this rather a minor problem. Another
problem is that this scale was not cross validated against
a current insomnia scale. We chose the PSQI because in
the evaluation period of the RIS there have been a lot
more studies done on insomnia patients with the PSQI
rather than the ISI. Furthermore, it was not our purpose
to design an alternative to ISI, but rather a new meas-
urement for psychophysiological symptoms and sleep
parameters in a short scale with good feasibility.
Conclusion
The RIS is a short, economic and valid instrument for
measuring psychological and physiological aspects of PI.
It specifically detects changes in target symptoms of
CBT-I typical for PI and thus represents an especially
well-suited instrument for assessing treatment effects of
insomnia specific CBT in both research and clinical use.
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